With a 'phenomenally successful' bench and regular involvement in high-end trials before UK and EU courts, Allen & Overy LLP remains a premier name for patent litigation, fielding a team whose 'brainpower and litigation firepower are not exceeded anywhere'. On the life sciences side, Marjan Noor, Marc Döring and senior associate Rafi Allos handle revocation actions and Supplementary Protection Certificate (SPC) validity proceedings, while Neville Cordell recently advanced infringement claims for transgenic mouse technology in a headline Supreme Court proceeding. Mark Heaney takes on disputes in the technology sector, including Standard-Essential Patents (SEP) and fair, reasonable and non-discriminatory (FRAND) licensing litigation for household names, while Mark Ridgway is the key name for trade secrets litigation. Jim Ford and Nigel Parker have a full-service commercial IP offering for collaboration and R&D negotiations and IP-rich M&A support. The Belfast-based Science Analyst team provides further technical know-how for complex contentious and non-contentious applications.
Intellectual property: patents (contentious and non-contentious) in London
Other key lawyers:
‘This is one of London’s foremost patent litigation teams. Marjan Noor has a phenomenally successful team dealing with the biggest of cases. The brainpower and litigation firepower here are not exceeded anywhere.‘
‘A superbly well-regarded firm with an increasingly strong presence in the TMT and Intellectual Property sectors. Having acquired experienced partners from other firms in the sector in recent years, the firm’s sector reputation is going from strength to strength, successfully attracting significant international clients away from well-known firms in the sector.‘
‘With an unrivalled depth of talent Allen & Overy have built a practice that is internationally renowned and the envy of the City.‘
‘Marjan Noor is THE life science patents litigator in London. Marjan is a wily tactician, a sharp intellectual lawyer, and a warm and fun human being. The model of a law firm partner in 2020.‘
‘Rafi Allos is a brilliant associate whose ability and instincts are extremely impressive.‘
‘Mark Heaney is exceptionally skilled, experienced and perceptive, rapidly grasping the perfect strategic approach in any case. He is fun to work with and leads his high-quality team with great skill.‘
‘Neville Cordell offers a steady hand in the biggest of international disputes, effortlessly coordinating multiple streams of activities to ensure a perfectly executed multijurisdictional approach.‘
‘James Fox is a pleasure to work with and a definite star of the future.‘
Eli Lilly & Company
GN Store Nord
Merck & Co.
- Defending Huawei in Conversant’s claim for a declaration that it offered FRAND terms in respect to its standard essential patent portfolio.
- Representing Regeneron in patent infringement litigation against Kymab concerning the client’s VelocImmune technology.
- Representing Eli Lilly in patent litigation against Genentech concerning the client’s anti-IL-17 antibody, Taltz.
Bird & Bird LLP’s expansive litigation bench fields sector-focused experts across life sciences, telecoms and AI (department co-head Katharine Stephens being a go-to name for the latter). Global biotechnology and pharmaceuticals clients use Neil Jenkins for bet-the-company litigation including infringement and revocation actions before the High Court, and Tom Snaith for high-value R&D and licensing transactions. Jennifer Jones and senior associate Christopher de Mauny have been working on disputes involving complex gene-editing technology while Morag Macdonald and Eleanor Root have recently issued infringement proceedings for the protection of medical devices. Jane Mutimear and Richard Vary represent tech and telecoms names (including Nokia and Ericsson) in cross-border SEP and FRAND licensing litigation, while co-head Robert Williams takes on trade secrets disputes. Numerous innovative tech tools are available to clients, including patent-valuation product ‘Pattern’ and a patent litigation project-management tool.
Other key lawyers:
‘They have in-depth knowledge and a breadth of expertise.‘
‘Zoe Fuller has outstanding attention to detail. She thinks outside the box and is a great problem solver. Zoe is incredibly capable and a huge asset to Bird & Bird.‘
‘Jane Mutimear is a brilliant patent litigator with impressive strategic skills and commercial awareness.‘
‘Richard Vary ticks all the boxes. He is a great patent litigator but also understands how individual litigation fits into the international stage. He fully appreciates all the competition law arguments, the economics, the technology and the industry.‘
‘James Pearson is smart, diligent and very client focused.‘
‘What sets Richard Vary apart is that he has long-term practical experience of real high-grade global IP litigation. That experience is invaluable in his day to day work both for case management as well as initial strategy development.‘
Fisher & Paykel Healthcare
B. Braun Group
- Represented Actavis in its successful revocation claim against ICOS/Eli Lilly’s dosing patent covering erectile dysfunction product Tadalafil.
- Acting for Sisvel International and Mitsubishi Electric Corporation on a High Court claim against multiple defendants in a FRAND licensing dispute.
- Defending AB InBev in High Court revocation proceedings brought by Heineken concerning two of the client’s European patents for polymer packaging technology.
Bristows LLP’s patents team comprises professionals with expertise across both contentious and non-contentious work, servicing clients across the life sciences, tech, engineering and mining industries. Litigation co-heads Andrew Bowler and Myles Jelf are involved in law-making SEP and FRAND litigation while Dominic Adair and Gemma Barrett have been involved in defending the protection of various antibody and biotechnology products. Greg Bacon takes on patent exhaustion claims; James Boon and Richard Pinckney reinforce the telecoms skillset; and Liz Cohen is a key name in the biosimilar space. The commercial side of the patents team comprises partners solely focused on non-contentious issues. Headed by Matthew Warren and featuring key names Brian Cordery and Claire Smith, this team handles market-leading licensing projects, collaboration deals and IP-rich investment transactions. Robert Burrows is an authority on the niche specialism of plant varieties, which is applied to contentious and non-contentious engagements.
Other key lawyers:
‘Top-quality litigators specialising in TMT and unparalleled knowledge of patent/competition crossover issues. A great team to work with.‘
‘The thing that sets Bristows apart is the depth of talent. It has a high number of eminent practitioner partners that are genuine experts in their fields. This is especially true in the patents space. However, below partner level, the lawyers are equally impressive. Unsurprisingly, Bristows has a blue-chip client base, especially in the pharmaceutical and biotech markets and is at the forefront of every legal development. Truly impressive. Their client service is of the highest quality and they are very easy to deal with.‘
‘There’s a style to the firm which enables them to be hard-headed and charming at one and the same time.‘
‘James Boon is an extremely sharp lawyer who always fights hard for the best for his clients.‘
‘Richard Pinckney is a clever and conscientious litigator.‘
‘Brian Cordery is the most knowledgeable UK patent lawyer I know. He is a standout. Cordery knows the pharma industry inside out and is very user-friendly.‘
‘Liz Cohen and Robert Burrows are very impressive, communicating clearly and being very astute when it comes to protecting their client’s interests.‘
‘Dominic Adair is a brilliant leader, creative thinker, and very commercial.‘
Johnson & Johnson
Kristian Gerhard Jebsen Skipsrederi AS (KGJS)
- Representing Chinese telecoms group ZTE in patent litigation brought by Conversant.
- Representing Heineken in a high-profile infringement claim brought by AB InBev concerning gas canister technology.
- Defending Philips in a revocation action brought by Garmin relating to the client’s GPS-based athletic performance monitor.
Hogan Lovells International LLP houses a number of highly praised patent litigators in London, including Paul Brown, Daniel Brook and Stephen Bennett. The team takes on complex disputes in the telecoms and life sciences sector, with recent Supreme Court and European Court proceedings concerning FRAND litigation and bet-the-company patent challenges to pharmaceutical products.
Buoyed by its reputation as a market-leading IP boutique, Powell Gilbert LLP is regularly involved in high-profile patent disputes before all levels of the UK courts. Indicative of the firm’s litigation strength, Simon Ayrton, Zoë Butler, Peter Damerell and senior associate Tess Waldron are representing global telecoms companies in law-defining FRAND litigation. Name partners Tim Powell and the 'highly knowledgeable and widely respected' Penny Gilbert (who acts as practice head) are frequently engaged by leading names in the life sciences sector to handle high-value litigation involving biosimilar drug products. Further novel disputes saw Powell, Siddharth Kusumakar (who recently made partner) and Bethan Hopewell handle patent infringement proceedings concerning next-gen heart valve technology and non-invasive prenatal testing technology. Expertise in the electronics, FMCG and media sectors is also cited. The team often develops multijurisdictional litigation strategy for clients, which involves opposition proceedings in the EU and US courts.
Other key lawyers:
‘Powell Gilbert has an industry-leading profile in UK TMT patent litigation. It is involved in pretty much all of the leading cases in this area, regularly acting for very large multinationals. Its involvement in the groundbreaking Unwired Planet v Huawei litigation is a good example of this.‘
‘Penny Gilbert is highly knowledgeable and widely respected- a great, and astute, co-ordinator of litigation.‘
‘Tim Powell is a tenacious and highly effective litigator who you do not want on the other side of a case.‘
‘Bethan Hopewell is resolute and determined.‘
‘Simon Ayrton combines excellent legal intelligence and insight with commercial strengths in planning and executing strategies in multijurisdictional disputes. I have worked with him for many years on dozens of cases and have seen first hand how much clients value his ability to see and plan all the many different facets of a dispute.‘
‘Zoë Butler is superb at leading and co-ordinating teams on the largest of cases. She is absolutely unflappable even in the most difficult situations, and brings integrity and honesty which clients really value.‘
‘Peter Damerell is probably the most analytically able lawyer I have worked with. On a very large FRAND case he produced a databook document for the court the like of which I have not seen before and which was incredibly impressive. He is also a determined litigator.‘
‘Tess Waldron is an extremely talented associate. She has an exceptional intellectual grasp of a case and produces excellent documents time and again. I have also seen her co-ordinate a very difficult matter to a successful conclusion in a manner that was very impressive indeed.‘
Huawei Technologies Co., Ltd
HEVC Advance LLC
Royalty Pharma Collection Trust
- Defending Lenovo in FRAND litigation advanced by IPCom.
- Representing Huawei in the Supreme Court in its landmark standards essential patents (SEP) dispute with Unwired Planet.
- Representing HEVC Advance (the administrator of the HEVC Advance patent pool), in an abuse of dominance/FRAND determination claim brought by Vestel.
Gowling WLG fields a vast bench of patent litigation experts including life sciences expert Paul Inman and TMT experts Alexandra Brodie (UK patents head) and Gordon Harris (global patents head). The addition of new recruits Huw Evans and Jon Ball (both from Norton Rose Fulbright) further reinforce the team’s fintech and medtech expertise. Ongoing trial work for the team includes multijurisdictional SEP and FRAND litigation, pharmaceutical patent infringement and revocation actions, as well as patent arbitrations for household-name electronics and aerospace clients. Patrick Duxbury and Luke Kempton advise on IP transactions out of the Birmingham office, with a strong presence in the life sciences sector. High-value collaboration deals, licensing negotiations and R&D agreements are regularly handled.
‘With the recent move of Huw Evans from Norton Rose Fulbright to Gowling, they have an almost unmatched technical patent litigation team.‘
‘Excellent lawyers. Very thorough and able to give practical advice.‘
‘Gowling has a very strong team with deep knowledge of many high-tech industries and wide experience of intellectual property issues.‘
‘Huw Evans is a remarkable lawyer. Intelligent, approachable, goes the extra mile, friendly, collegiate, with very extensive experience, especially of patents.‘
‘The team has a number of great litigators, all commercially minded. They are very responsive and give clear, well-considered advice.‘
‘Fabulous people who really understand what the developments in the industry are. Very innovative.‘
TQ Delta, LLC (“TQD”)
Hexatronic Group AB
Black Belt Therapeutics Limited
- Acted for GlaxoSmithKline in the UK arm of an international dispute concerning technology for the formulation of very fine powders used in certain inhaler products, which form an important part of the client’s portfolio.
- Acted for TQ Delta in an international dispute concerning digital subscriber line (DSL) technology used in broadband internet connections.
- Acted for Hexatronic, a global leader in fibre optic cable technology. Emtelle issued UK proceedings claiming that Hexatronic had infringed two of its UK patents relating to the design of thermoplastic outer sheath coatings of air-blown fibre optic cables.
Herbert Smith Freehills LLP
Herbert Smith Freehills LLP provides 'encyclopaedic knowledge' of patent litigation and commercialisation under the leadership of Joel Smith. The team routinely handle cutting-edge R&D, collaboration and licensing deals (and related disputes) on a global scale, in sectors as diverse as genetics, mining and FMCG. Jonathan Turnbull focuses on the exploitation of blockbuster drugs for pharmaceuticals companies, with Sophie Rich and Sebastian Moore also active in the life sciences space. Headline work in this are includes multijurisdictional Supplementary Protection Certificate (SPC) litigation and enforcement actions against generics companies. Andrew Moir is noted for handling hi-tech patent litigation for telecoms, software and broadcasting clients, including FRAND licensing and SEP disputes. Mark Shillito, the firm’s global IP head, also sits in London.
Other key lawyers:
‘A class act, at the absolute top of their game. They have a wealth of experience and a team with outstanding depth of resources. They are astute and extremely commercial and have a great ability to distil the issues in complex cases into a format and message that is easily understood by clients. They are also a pleasure to deal with.‘
‘User friendly, pragmatic advice and joined up with colleagues in other practices within the firm. Commercial in outlook but underpinned by unquestionable legal knowledge.‘
‘Joel Smith is a true expert in his field. He has an encyclopaedic knowledge of IP and whilst ruthless in litigation matters is extremely calm considered and reassuring.‘
‘Andrew Moir is very clever indeed.‘
‘Sebastian Moore really takes the time to get completely on top of his cases, and runs a well-organised team who plainly love working for him.‘
‘Andrew Wells not only has the ability and dedication to do the work of an associate extremely well, but also has the strategic ability that will surely make him a partner soon.‘
‘Jonathan Turnbull is extremely diligent- he does not miss a point or leave anything to chance. He will work through the night to get even relatively minor points done. This is generally the Herbert Smith Freehills way, but I would say Jonathan Turnbull is a particularly good example of this. He also has very good knowledge of the pharma/biomedical industry.‘
‘Victoria Horsey, Jessica Welborn and Joanna Silver are all very responsive and provide well-considered advice.‘
F. Hoffmann La-Roche AG
Roche Products Limited
British Society of Plant Breeders Ltd
British American Tobacco
- Advising Roche/Genentech on their pan-European patent enforcement strategy for blockbuster anticancer drug AVASTIN® (bevacizumab), a monoclonal antibody.
- Represented Unilever in the Supreme Court against a multimillion-pound claim by a former employee for compensation in respect of inventions made during the course of his employment.
- Advised Genus – a UK-listed animal genetics company – on its strategic and cutting-edge collaboration and licensing deal with Beijing Capital Agribusiness Co. to research, develop, register and market (in China) pigs resistant to Porcine Reproductive and Respiratory Syndrome virus (‘PRRSv’).
‘Force to be reckoned with’ Nicola Dagg leads the rapidly expanding patent litigation practice at Kirkland & Ellis International LLP. Dagg, Daniel Lim and Katie Coltart have represented high-profile companies in the life sciences sector on market-defining patent trials before all levels of the UK courts, as well as handling parallel infringement proceedings concerning cutting-edge biotechnology innovations, and damages cases on behalf of global pharmaceuticals companies against generics companies. In the TMT space, Lim and Steven Baldwin are leading on major SEP and FRAND litigation proceedings for global telecoms corporations. Patent licensing disputes – including for the determination of royalty rates in the smartphones space – are also underway. 'Powerhouse' partner Jin Ooi is another noteworthy name. The team also offers non-contentious commercial IP and collaboration advice.
‘The Kirkland team is truly amazing with an incredibly high quality, both in tech and in life sciences. They excel on every front. Very quick, very responsive and with a thorough analysis. Laser-focused on strategy from the outset, with a clear plan for how to achieve the best result and then works extremely hard to make sure it happens.‘
‘Jin Ooi’s knowledge of second medical use issues is market leading.‘
‘Nicola Dagg is an excellent strategist and very valuable in advising on overarching strategic considerations in complex global patent disputes.‘
‘They push the envelope on strategic advice and thinking.‘
‘Nicola Dagg and Katie Coltart are fantastic. They are unique due to their clever strategy, their high reactivity and their winning spirit. And they are enthusiastic, which makes working with them a great pleasure.‘
‘Nicola Dagg is a force to be reckoned with and is great at getting the right people involved whether it’s mobilising client staff, barristers or experts’
Jin Ooi is a powerhouse and is always available and highly responsive. He is a master of detail and able to clearly explain complex issues.’
‘Nicola Dagg, Daniel Lim and Stephen Baldwin are the types of attorneys that any in-house attorney would love working with. They give good, practical advice but have a keen sense of not wasting time. I completely trust them and the team.‘
British American Tobacco
Arsenal Capital Partners
Bain Capital and Cinven Partners
Meril Life Sciences
- Acting for Regeneron in its complex and hard-fought patent litigation against Kymab up to the Supreme Court. The litigation relates to Regeneron’s proprietary transgenic mouse platform for therapeutic human antibody development, VelocImmune.
- Instructed by Lenovo, the largest PC manufacturer in the world, and Motorola Mobility, a leading smartphone manufacturer, in relation to a major SEP/FRAND worldwide licensing dispute brought by Interdigital Technology Corporation.
- Instructed to represent Xiaomi, the world’s fourth largest smartphone manufacturer, in relation to a SEP/FRAND worldwide licensing dispute brought by Sisvel International SA and Mitsubishi Electric Corporation in the English High Court.
International IP boutique Marks & Clerk LLP fields a team of patent litigators that frequently represents global clients in disputes before the High Court. Mike Gilbert heads the life sciences service line with support from Trevor Crosse and managing associate Ian Turner. The team is involved in a suite of disputes concerning SPCs alongside numerous enforcement and validity actions for high-profile biopharmaceutical companies. Dafydd Bevan (head of high-tech), of counsel Gregor Grant and managing associate Will Jensen are currently involved in multijurisdictional infringement litigation concerning machinery for a global mechanical engineering client. On the telecoms side, Graham Burnett-Hall is a go-to name for litigation in the complex field of FRAND licensing. Commercial patent matters – including licensing deals and strategic advice – are handled by Michael Moore.
‘Very experienced and respected team, very good value for money, transparent, open to dialogue, well able to handle technically complex cases.‘
‘Mike Gilbert is very experienced and respected, capable of handling legally and technically complex cases. He is pragmatic and sees the whole picture when providing legal advice, has a really good knowledge of the pharma/life sciences industry, and stays calm under pressure. He is client oriented, and transparent and open to discussion about case management, resource allocation etc. He works very well with others in multi-country litigation situations. A great team leader.‘
‘Strategic thinkers with deep substantive knowledge and the ability to distil complicated aspects of UK law into (relatively) straightforward decision points. Marks & Clerk would definitely be my go-to choice for UK counsel.‘
‘Mike Gilbert, Trevor Crosse, and team have demonstrated excellent writing skills, commitment to our files, and an ability to quickly get up to speed on complicated matters.‘
F. Hoffmann-La Roche
Manitou BF & Manitou UK Limited
dSPACE Digital Signal Processing & Control Engineering GmbH
- Acted for Genentech in three related infringement and validity actions concerning Eli Lilly’s anti-IL17A/F antibody product, Taltz.
- Acted for Manitou in a patent infringement and validity action against JCB relating to control systems for heavy machinery.
- Acted for Pfizer in a patent revocation and infringement action in relation to the formulation of pneumococcal vaccines.
Pinsent Masons LLP
Practice head Clare Tunstall (dubbed 'Queen of the generic revocation case' by clients) and Charlotte Weekes of Pinsent Masons LLP recently represented Teva Pharmaceutical Industries in the headline claim for revocation of Gilead’s SPC for the Truvada HIV treatment, indicative of the firm's involvement in law-defining patent litigation. Further revocation actions saw Christopher Sharp protecting blockbuster pharmaceutical products before the UK Patents Court. The addition of Nicole Jadeja from Fieldfisher further expanded the team’s enforcement capabilities, while in the TMT sector, Iain Connor is a go-to name for FRAND licensing and SEP infringement actions. The team also handles disputes in the energy sector, while Allistair Booth takes the lead advising on high-value licensing, collaboration deals and portfolio acquisitions in the generic pharmaceuticals sector.
Other key lawyers:
‘The Pinsent Masons IP team is as strong and mighty as any of the other London IP teams who own more of the limelight. They have been building capability and investing in the stars of the future; razor sharp and energetic junior partners. I strongly believe that they put the client first and understand this is the path to long-term relationships and success.‘
‘A really first-class firm that has very strong partners and associates.‘
‘The team is able to take complicated issues, come up with a simple and pragmatic strategy, execute it and deliver what is needed. I have worked with other IP teams who flounder around with complexity and posturing and are incapable of delivering a result. The Pinsent Masons team know their law, but are able to exercise enough pragmatism to deliver a result.‘
‘Christopher Sharp is the best. Astute, assured and unflappable. Everything is can-do, delivery is efficient, communication is great and preparedness is excellent. He is a first-class litigator: pushes the right buttons at the right time to bear maximum pressure, and selects the right strategy and tactics for the case rather than drawing from a one-size-fits-all playbook.‘
‘I have worked with Nicole Jadeja on a number of matters and I am always impressed with her thoughtful, practical and clear advice. She has great experience working with small biotech companies and is incredibly responsive and helpful.‘
‘Charlotte Weekes is an excellent patent litigator. Clever, knowledgeable and focused on the client’s commercial imperatives.‘
‘Clare Tunstall is the “Queen of the generic revocation case”. She has done more than anyone else and knows the ropes inside out. She is also fantastic to work with – nothing is too much trouble. Clients love her.‘
‘Charlotte Weekes and Samantha Carter are absolute stars.‘
Teva Pharmaceutical Industries Limited
Badoo / Bumble
Juul Labs Inc.
East Anglia One Ltd
ZyXEL Communications UK Limited and ZyXEL Communications A/S
Safran Seats GB Limited
BGMA – British Generic Manufacturers Association
MfE – Medicines for Europe
IP Group Limited
4D Pharma PLC
C4X Discovery PLC
IBSA Institut Biochimique
Zentiva Group a.s.
- Acted for ZyXel in two separate actions each asserting infringement of two standard essential patents (SEPs). The technology in suit is ADSL2, ADSL2+, and VDSL2 technology used in WiFi routers and networking equipment.
- Advised Teva Pharmaceutical Industries in a challenge to the validity of two patents for tadalafil.
- Acting for JUUL on all brand enforcement activities in the UK, including in relation to counterfeit goods, compatible products and copycat products.
Simmons & Simmons
Simmons & Simmons has a strong patent litigation offering across the life sciences and technology fields provided by Michael Burdon and Scott Parker. Ongoing proceedings before the High Court and CJEU involve the defence of injunction applications and headline SPC litigation concerning blockbuster HIV treatments. Practice head Michael Gavey has a focus on non-contentious issues, including cross-border AI and technology collaboration agreements, R&D projects in the healthcare space and IP-rich M&A due diligence. Angus McLean is the go-to fintech expert, often handling complex collaboration agreements for established and early-stage clients.
‘Highly efficient coordination within the team, cost effective, accurate understanding of clients’ business needs and proactive support’
‘Top-quality legal analysis and very professional’
‘Excellent outside counsel.‘
Boston Scientific Corporation
Alzheimers’ Research UK
OGCI CI LLP
Mitsubishi UFJ Trust & Banking Corporation
The Institute of Cancer Research
Eli Lilly and Company
- Defending Gilead in High Court proceedings and the subsequent appeal following the CJEU decision, in revocation claims by four generics companies against the SPC for Gilead’s blockbuster HIV drug TRUVADA®.
- Acted for Samsung Bioepis in two separate actions concerning adalimumab formulation patents held by Fresenius Kabi and Gedeon Richter, and coordinating numerous parallel European cases.
- Advising GlaxoSmithKline on a range of cutting-edge transactions and strategic research collaborations, including multiple complex projects funded under the EU Innovative Medicines Initiative and Horizon 2020.
Taylor Wessing LLP’s patent expertise cuts across the life sciences and TMT sectors. Nigel Stoate heads the practice and has a strong reputation for devising global patent litigation strategy in highly technical areas; recent instructions have involved heart valve technology, blockbuster cancer treatments and other surgical devices. Recent successes for Stoate and Simon Cohen have involved infringement and invalidity proceedings before the UK Patents Court. James Marshall is the name to note for telecoms expertise including SEP and FRAND litigation, with the team also advising on trade secrets litigation in the technology sector . The commercial IP offering at partnership level has been enhanced with the promotion of Colin McCall, with the team handling licensing, manufacturing and collaboration agreements in the medtech and life sciences sectors.
‘The team is highly knowledgeable and provides practical business solutions.‘
‘Taylor Wessing has an impressive group of trade mark attorneys, who each have a niche within the practice.‘
- Advising ASUS (and subsidiary companies) on its patent litigation strategy across Europe in relation to patent infringement actions brought by Philips concerning its mobile phone technology.
- Working with a major network operator customer (to whom Ericsson has supplied base stations/infrastructure) in respect of a dispute regarding standard essential patents owned by a third party.
- Successfully represented Abbott Laboratories, a long-standing client, in commercially significant patent litigation, defending MitraClip, Abbott’s breakthrough transcatheter mitral valve repair product.
Baker McKenzie’s patent expertise is frequently applied to multijurisdictional commercial and transactional engagements in the life sciences and TMT sectors. The team works on high profile licensing and R&D collaborations, with recent highlights including work involving cochlear implants and blockbuster drugs. Practice head Hiroshi Sheraton takes the lead on contentious matters, with recent instructions involving cross-border patent infringement proceedings across a diverse set of sectors, including heavy construction, cosmetics and pharmaceuticals. Associate Tanvi Shah regularly assists across both contentious and non-contentious issues.
Other key lawyers:
‘The practice provides a comprehensive coverage of the IP space, both from a geographical and issue perspective. The advice is well coordinated, with the appropriate people brought into play as needed.‘
‘The individuals I work with at Baker McKenzie understand our business and the level of input we require. Their advice is comprehensive and highly tailored to our needs.‘
- Acted for Japanese conglomerate Hitachi on its $11bn energy joint venture with Swiss engineering group AB.
- Representing L’Oréal in a global patent dispute with US company Olaplex regarding a patent that is alleged to cover the client’s Smartbond product.
- Representing JCB in a claim for infringement of five patents relating to safety systems applied to telescopic handlers against French competitor Manitou.
The patent litigation experts at CMS are experienced in running High Court proceedings for global life sciences clients. Recent successes for practice head Gareth Morgan and Caitlin Heard have involved defending patent infringement claims in the generic pharmaceuticals space, and SPC entitlement claims centring on chemical-modification technology (the latter involving EPO oppositional proceedings). Sara Hanson , who co-heads the firm’s life sciences and healthcare vertical, provides valuable technical input. The firm is also involved in validity actions for cybersecurity products, while on the non-contentious front it has been involved in collaboration and licensing deals in the energy and construction sectors.
‘Very responsive and dynamic. Legal advice is presented in a clear form with the benefit of the headline answer as well as the granular detail. Very creative in forming solutions to legal support- focus is on the best solution for the client, and not the one that gives the most fees.‘
‘Caitlin Heard and Melanie Worsdall are a pleasure to work with. Nothing is too much trouble and every deadline is met, even the unreasonable ones!‘
‘They are very responsive and client driven.‘
‘Sarah Innes and Gareth Morgan have excellent knowledge, particularly of the complex interactions between regulatory and patent law. They are always up to date, creative and proactive.‘
Estar Technologies Limited
- Acted for Sandoz in high-value damages proceedings brought against Napp Pharmaceutical Holdings arising from Napp having been granted an interim injunction on a patent proven not to be infringed.
- Acting for Estar before the Court of Appeal on an appeal of a patent infringement and validity decision in Regen v Esta.
- Acted for cybersecurity company Clearswift in a landmark patent case initiated by Glasswall regarding an anti-malware patent.
EIP’s patent litigation experts are market leaders in the field of FRAND litigation in the telecoms sector, having spearheaded numerous high-profile trials in the Supreme Court and Patents Court under the guidance of Robert Lundie Smith, Matthew Jones, Andrew Sharples and 'totemic strategist' Gary Moss, who heads the practice. According to one client the firm has 'virtually cornered the market in acting for telecoms patent holders seeking FRAND royalties for their patent portfolios'. New joiner Kathleen Fox Murphy from Browne Jacobson LLP further enhances this expertise, while also reinforcing the team’s expertise in the pharmaceuticals and emerging technologies sectors.
‘EIP has built a strong reputation as a market-leader acting for patentees in patent licensing disputes in the telecoms arena, in particular where a patent portfolio is sought to be licensed on a FRAND basis. EIP comprises both solicitors and patent attorneys, and the mix of the two is a considerable strength since the patent attorneys have deep expertise in telecoms technology, so they have vital input into the technical aspects of the cases. On the solicitor front, considerable expertise of this sort of dispute has now been amassed.‘
‘Relatively small but highly effective team of IP litigators.‘
‘EIP have virtually cornered the market in acting for telecoms patent holders seeking FRAND royalties for their patent portfolio’
‘Very commercially focused, with wide strategic and tactical experience, and a huge depth of highly skilled technical knowledge.‘
‘Rob Lundie-Smith is a stand-out partner. He is extremely hardworking, has a strong grasp of the issues and really thinks around the problems. He is also unfailingly good-humoured, courteous and a pleasure to work with, even in times of great stress.‘
‘Gary Moss, as the senior partner, has an encyclopaedic knowledge of FRAND disputes, and is the tactical powerhouse behind EIP.
‘Gary Moss is a totemic strategist, with unparalleled experience in large-scale telecoms litigation. There is not a trick in the book that he doesn’t know, of which there are few that he didn’t create himself.‘
- Steered Conversant through first instance and Court of Appeal jurisdictional challenges from Huawei and ZTE (with Supreme Court judgment pending) while successfully proving the validity, essentiality and infringement of two of its Standard Essential Patents thereby securing a FRAND trial.
- Continues to advise client Unwired Planet in its FRAND and SEP patent dispute against Huawei before the Supreme Court.
- Represented ClearCorrect in a four-patent medical device dispute against Align Technologies before the High Court.
Linklaters LLP 's City team helps defend pharmaceutical and biotech companies in cross-border patent litigation. The client base for Ian Karet (who heads the practice) and Yohan Liyanage includes high profile multinationals owning complex medical treatments and antibodies. Non-contentious support on collaborations, licensing deals and corporate transactions is carried out by Karet and Nemone Franks, with work highlights including multibillion-dollar patent portfolio sales in the skincare market.
‘The team is very knowledgeable of the law and the industry, and conscientious and pleasant to work with.’
‘I worked with Ian Karet on a patent litigation matter which changed the law in the UK and influenced the law in many other countries. I think he has a very unique way of seeing things, and can quickly review vast amounts of complex materials and provide direct, insightful, straightforward, advice and would like to work with him on more patent matters.’
Merck & Co, Inc.
Fnality International Limited
- Advising Sanofi and Regeneron on a cross-border patent dispute with Amgen relating to monoclonal antibody products used to treat cardiovascular disease.
- Advised Nestlé on the £8bn sale of its skincare business, Nestlé Skin Health.
- Acting for VHsquared, a UK biotech company, and a number of Unilever companies, in defending a patent infringement claim by Ablynx, a Dutch biotech company, in relation to a patent for the use of single-chain, camel-derived antibodies.
The patent litigation experts at Mishcon de Reya LLP advise on multijurisdictional enforcement and litigation proceedings across a range of IP-rich sectors. Practice leader David Rose – assisted by associates Victoria Wilson and Anaar Patel – is representing numerous generic pharmaceutical companies in high-impact invalidation proceedings against Gilead’s SPC for HIV treatment Truvada. Martyn Hann tackles commercial IP issues ranging from licensing agreements to funding applications; predominantly for life sciences clients, with additional work coming from the energy and burgeoning medicinal cannabis sector. Jeremy Hertzog has experience advising international telecoms companies on breach of confidentiality and patent infringement proceedings against Vodafone, with legal director Peter Nunn assisting.
‘Mishcon de Reya brings a wealth of experience from a broad spectrum of IP litigation to enable it to successfully tackle any type of intellectual property issue, especially for large clients who want an individual approach to their case and their business.‘
‘Although Mishcon de Reya are primarily known for their soft IP and media work, they now also have a very good hard IP/patent practice. David Rose has brought considerable experience in this field to them, including telecoms litigation (which is a sub-speciality in itself!)The team is well set up for high-value patent cases and understands well the strategic role this type of litigation can play.‘
Lupin Limited and Lupin (Europe) Limited
Top Optimized Technologies S.L
TOT Power Control S.L.
Dr Reddy’s Laboratories Limited
Wolf Formulations Limited
- Acting for Lupin in successful invalidity proceedings against Gilead’s supplementary protection certificate for Truvada in the Court of Appeal.
- Acting for Top Optimized Technologies and TOT Power Control in patent infringement proceedings against Vodafone.
- Acting for Dr Reddy’s Laboratories Limited in a damages enquiry under a cross-undertaking, against Warner-Lambert relating to its second medical use patent concerning pregabalin.
Osborne Clarke LLP’s patent litigation practice regularly represents TMT clients in complex IP litigation involving high-tech elements such as AI, blockchain and telecoms devices. SEP and FRAND disputes are a point of strength for practice head Arty Rajendra, evidenced by her leading role co-representing Unwired Planet in headline litigation before the Supreme Court. In addition to litigation, recent hire Will James (previously with Marks & Clerk Law) takes on commercial IP matters including cross-border collaboration agreements in the technology sector. Also new to the team, associate director Chris Pratt fields expertise in life sciences. Recent engagement on this side has involved advancing infringement proceedings for biotechnology clients.
‘Will James recently came over from Marks & Clark. He is truly a boost to the team and Osborne Clarke have a wonderful future ahead with him on board.‘
‘Will James stands out in life sciences litigation. He has a very bright mind, is a wonderful organiser and among the best in coordinating complex cross border cases.‘
‘Will James has been in the IP sector for 15 years. He knows the science as well as the law. His client advice and ability to coordinate international cases is outstanding.‘
Unwired Planet LLC
- Acting as co-counsel for Unwired Planet in the landmark case against Huawei concerning Standard Essential Patents and FRAND licensing.
- Advising a major biotechnology client in its European and UK litigation strategy in respect of an intensely competitive new clinical field of therapeutics.
- Representing PopSockets in a case concerning patent infringement and invalidity between PopSockets and Quest USA.
Stephenson Harwood’s head of patents and 'brilliant scientific mind' Alexandra Pygall has a focus on patent licensing, transactions and other commercial endeavours, typically involving high-value, multijurisdictional deals in the life sciences sector. The firm also advises on matters for clients in the consumer goods sector. Rob Jacob leads on contentious instructions, including for big-ticket clients in the energy and oil and gas sector. Recent litigation has involved complex patent infringement defence of heavy machinery systems and infringement claims involving drilling technology.
Other key lawyers:
‘Highly experienced in pharmaceutical and life sciences.‘
‘Alexandra Pygall is an excellent leader.‘
‘Highest quality of work I have encountered so far in my career, with unprecedented back office support. Rob Jacob knew which strategy to adapt in any scenario and knew the approach to take in any situation.‘
‘Fantastic high-quality service and work product, with personable people, at value-for-money prices.‘
‘Knowledgeable, pragmatic, sensible and appropriate advice and stellar service.‘
‘Alexandra Pygall has deep understanding of the commercial requirements of the TMT and life sciences sector. She leads an impressive team.‘
‘Alexandra Pygall has a brilliant scientific mind.‘
‘Rob Jacob: fantastic in-house experience and a creative thinker.‘
Cell Medica Ltd
Lucozade Ribena Suntory
Shield Therapeutics Plc
Philex Electronic Limited
Smart Reamer Drilling Systems Limited
Oxford Biomedica plc
Johnson & Johnson Innovation
- Acted for Eureka Shipping Limited, Parainen Pearl Shipping Limited and SMT Shipping in proceedings concerning a cement carrier vessel, which contains a pneumatic system for unloading dry cement. Acted for claimants that successfully sought a declaration of non- infringement in respect of the UK designation of EP’426.
- Advising Oxford Biomedica – a listed company that manufactures and develops viral vectors for use in conjunction with gene therapy products – in relation to a number of contracts with third parties regarding use of the client’s technology/IP in manufacturing the third party’s products.
- Acted for Shield Therepeutics in relation to the negotiation of an exclusive licence to Norgine B.V. for the right to exploit the patent portfolio related to the “Feraccru” product for the commercialisation of it in Europe.
Wiggin LLP boosted its team in summer 2020 with the hire Barclays former global IP head Calum Smyth. The practice handles a range of patent litigation work and has been involved in a number of noteworthy High Court trials, with Michael Browne handling entitlement disputes in the construction sector and practice head Sara Ashby involved in defending infringement claims in the horticultural equipment sector. Disputes across the life sciences, medical devices and automotive sectors are also regularly handled, with support from senior associates Victoria Gyles, Maeve Lynch and Flora Greenwood.
‘Very responsive, on target practical advice, cost-efficient litigation.‘
‘Wiggin are superb.‘
Permavent Limited & Greenhill Industrial Holdings Limited
Kevin Nash Group Plc and Nash Tackle Limited
BPW Bergische Achsen KG
- Acted for Hozelock in its successful defence of High Court patent infringement and validity proceedings which went to trial in February 2019.
- Acting for claimants Permavent in High Court proceedings relating to a long-running patent entitlement dispute with an ex-director. Obtained interim injunctions against the defendant on an ex parte basis.
- Acted for MacGregor Healthcare in successful (and long-running) defence patent infringement and validity proceedings relating to medical devices (catheters).
Carpmaels & Ransford LLP continues to expand its patent litigation offering under the guidance of Camilla Balleny and disputes practice head David Wilson. Life sciences is a sector of focus and recent highlights involved defending revocation and infringement proceedings for global pharmaceuticals clients. A transactional practice is also provided under Jake Marshall, who fields expertise in devising high-value collaboration agreements for blockbuster medicines including for HIV treatment. Marshall also handles oppositions, licensing agreements and portfolio acquisitions.
Other key lawyers:
‘Combining a litigation team with a heavy-hitting patent attorney firm has been a resounding success. Carpmaels provides a fantastic one-stop offering at the highest level, with really fruitful results.‘
‘Camilla Balleny is a warm and personable adviser who is justifiably loved by her clients. With her technical background and considerable litigation experience, she is an excellent person to have on-side.‘
‘David Wilson is a calm head in the throes of a challenging case and is able to draw on considerable experience. He provides sound advice and a reassuring presence to clients.‘
BISSELL Homecare, Inc.
BMS (formerly Celgene)
Foundation Hubrecht Organoid Technology
- Regularly defending BMS (formerly Celgene) in patent disputes brought by generic pharmaceuticals companies.
- Prosecuting patents and defending opposition proceedings on a long-term basis for FibroGen.
- Defending BISSELL Homecare in patent infringement proceedings filed by Philips.
The patent group at Dentons maintains a solid reputation for patent litigation under practice head Campbell Forsyth. With assistance from associates Jennifer Cass and James Marsden, Forsyth is handling High Court proceedings concerning patent infringement and validity, SPC licensing and Arrow declarations for technology and pharmaceuticals companies. A team led by European patent head Justin Hill offers the full scope of commercial, advisory, transactional and prosecution services (registered patent attorneys sit within the team). High-growth technology clients are a focus.
‘The team is formed by competent, organised, efficient people.‘
‘A very thorough approach to numerous difficult issues in a complex patent case.‘
‘Campbell Forsyth, partner, is ably assisted by his very well-organised and meticulous associate, James Marsden.‘
Cavour Limited and Lottoland Holdings Ltd
Royal Mail Group
BNF Capital Limited
Emtelle UK Limited
LGC Science Group Holdings Limited
Lottoland Holdings Ltd
Seraphim Space Camp Accelerator Ltd
To add more
- Representing Emtelle before the High Court in a high-value patent infringement and validity case relating to fibre optic cabling.
- Handling Zentiva’s claim to invalidate a Supplementary Protection Certificate held in the name of Gilead Sciences for an anti-retroviral drug used to treat HIV.
- Managing the European patent portfolio of Raytheon Company and its various subsidiaries.
Fieldfisher’s patent litigation practice has a focus on the life sciences sector under practice head David Knight, who has a strong industry reputation in the field of SPC litigation. Recent successes for Knight, senior associate Tommy McKenna and associate Christopher Leung have involved proceedings before the Court of Justice of the European Union (CJEU) and UK Intellectual Property Office (IPO) for generics companies. The team has also taken on patent litigation instructions from clients in the aviation and medical supplies sectors.
‘Small, focused, hands on, efficient, gets right to the heart of the matter.‘
‘Chris Leung is outstanding; a star of the future. Fantastic grasp of issues, good attention to detail, really thinks about the case and understands the interplay between argument and strategy.‘
‘No fluff, able to read a room and react appropriately and sensitively to internal stakeholders.‘
‘David Knight and Christopher Leung are a great pairing and work seamlessly with counsel. David is an unflinchingly practical and realistic lawyer.‘
Hexal AG and Sandoz Ltd
Master Data Center Inc (a CPA Global
- Acted for Sandoz Ltd and Hexal AG, companies within the generics arm of Novartis, in a dispute concerning the interpretation of the SPC Regulation.
- Represented Master Data Center in an application before the UKIPO to rectify the register in regards to the expiry date of an SPC, and on appeal to the Patents Court.
Jones Day provides patent litigation expertise in the fields of biotechnology, pharmaceuticals, aerospace and wireless technology under practice head Alastair McCulloch. Recent instructions have involved patent revocation defence and the advancement of blockbuster drug infringement actions in the High Court. McCulloch is currently acting for Lufthansa as claimant in a Patents Court dispute concerning an aircraft passenger power supply system.
Reed Smith LLP
Reed Smith LLP’s patent litigation expert Jonathan Radcliffe is involved in pan-European and pan-Atlantic disputes in the sectors of technology, chemical production, healthcare and manufacturing. Complex infringement questions surrounding repurposed and reconstructed technological devices constitute ongoing highlights. Regulatory advice in respect of emissions technology, and exploitation advice for mobile phone technology, are also provided.
RPC provides patent licensing, exploitation and collaboration advice to companies in high-tech sectors including augmented reality, electronics, engineering and digital media. Stand-out names in the team include practice head Jeremy Drew, Paul Joseph, Ciara Cullen and David Cran. Unique to the team is its involvement in complex insurance-related patent disputes, which sees the team defending global insurance companies in coverage litigation relating to patent portfolios. A number of telecoms clients also retain the team for advice on SEP and FRAND licensing issues.
‘David Cran is personable, very intelligent and quick to get to the nub of the problem.‘
‘A brilliant firm.‘
Ceres Power Limited
Heidelberg Engineering GmbH
- Instructed to assist Ceres Power on a large number of IP/patent licence agreements with third-party technology development partners across the world. This work involves advising on, drafting and negotiating complex IP provisions relating to, amongst other things, the ownership and licensing of project IP and cross-licensing of background IP.
WilmerHale’s patents offering made its mark in the field of FRAND licensing litigation through Anthony Trenton and Matthew Shade’s representation of multinational clients in high-profile proceedings in parallel with their US counterparts. Complementing that, key team members Justin Watts and Trevor Cook are noteworthy for handling pan-European patent infringement litigation in the pharmaceuticals and technology sectors including EPO opposition proceedings.
Other key lawyers:
‘I cannot rate WilmerHale too highly- the quality of their patents team is exceptional, world class, and it has been an absolute pleasure to work with them. They combine deep legal knowledge with the ability to get completely on top of the difficult technology involved. Highly creative, sound judgement. Cannot praise too highly.‘
‘Justin Watts is a bundle of energy, creative but based on deep knowledge of the law.‘
‘Christina Guazzi has a clear grasp of the technology, the needs, and has great people skills too.‘
‘Annsley Merelle Ward showed very effective management of the issues with clear direction and focus.‘
- Advising Bristol-Myers Squibb in preparation for anticipated UK litigation and coordinating pan-European litigation in relation to one of the highest revenue pharmaceuticals on the market.
AA Thornton offers expertise in patent disputes, commercial IP matters and licensing negotiations and advises a range of high-profile clients. Recent instructions for practice head Geoff Hussey have involved cross-border patent revocations and patent infringement claims before the Intellectual Property Enterprise Court (IPEC), and highly complex breach-of-confidence and patent entitlement disputes regarding quantum computing technology. Other sectors of strength include life sciences, medical devices and electronics.
Exceptional knowledge and experience in complex IP litigation, including in the area of complex emerging technologies.
Geoff Hussey – two words – he wins.
Geoff Hussey simplifies everything and makes managing litigation easy for in-house counsel. A strategic, pragmatic and commercially minded lawyer, he knows how to read adversaries and when to apply leverage. Straightforward and easy to work with.
Adolf Nissen Elektrobau
Cambridge Quantum Computing
Halliburton Energy Services
Bial – Portela & CA
- Represented Adolf Nissen Elektrobau before the IPEC in the successful revocation of Horizont Group’s patent for a mobile road traffic warning device.
- Handling a breach-of-contract, breach-of-confidence and patent entitlement dispute for claimant Cambridge Quantum Computing against River Lane Limited. The case concerns the complicated technology of quantum computing software for quantum chemistry.
- Defended medical diagnostics company RSR against a nullity action brought by Aesku.
Arnold & Porter’s recent recruitment of Beatriz San Martin to the partnership from Fieldfisher has significantly expanded the patent litigation capabilities on offer from London to the firm's global life sciences client base. San Martin fields particular expertise in SPC invalidity actions before the UK and European courts. Recently made-up partner Ewan Townsend handles commercial IP issues, including ongoing R&D and collaboration negotiations involving complex biotechnology and pharmaceutical products.
Other key lawyers:
Bristol-Myers Squibb (BMS)
Leading DNA synthetic company
Charles Russell Speechlys LLP handles patent disputes across the TMT, life sciences and engineering sectors, with go-to names including associate David Fyfield, practice head Mary Bagnall and consultant Ian Wood. The team regularly handles licensing disputes, patent revocation actions and patent infringement claims. Senior associate Caroline Young leads on commercial IP matters. Recent highlights in this space have included R&D and clinical agreements for vaccinations, licensing negotiations for pharmaceuticals companies and patent acquisitions in the field of epilepsy treatments.
‘Good ability to deal with complex patent disputes, especially in chemical and medical device sectors. An experienced team who are a delight to work with.‘
‘Ian Wood draws on a wealth of experience to obtain great results for his clients.‘
‘David Fyfield is an enthusiastic associate and valuable member of the litigation team.‘
National Pharmacy Association Limited
Energy Technologies Institute
Next Control Systems
- Retained by Sandvik Group to handle patent disputes concerning its mining machinery and equipment.
- Advised Deepak Nitrite on a patent revocation case involving chemicals used for brightening and lightening paper.
- Advising an energy and renewables company on the funding, design and construction of an innovative gasification plant reliant on an extensive patent portfolio.
Clyde & Co LLP is retained by pharmaceuticals clients in the generics market to handle patent litigation and non-contentious engagements. Practice head Ralph Cox has conducted trials including infringement and invalidity defence relating to prenatal testing patents before the Patents Court. Patent licensing disputes in the manufacturing and engineering sectors are also handled, as well as revocation proceedings on behalf of veterinary pharmaceuticals clients. The breadth of commercial issues including freedom-to-operate strategy is provided to all clients.
‘Particular strength in life-sciences, where there is deep industry knowledge and capability.‘
‘Ralph Cox is a highly impressive patent lawyer- I would rate him as exceptional, and one of the very best I have worked with. His knowledge of the industry and the law is exceptional, and he is equally at home dealing with contentious and non-contentious work. Ralph manages somehow to be able to absorb and process all of the detail while also maintaining a high-level view of the case, transaction or advice at hand, which means he is able to provide user-friendly commercial advice to clients.‘
‘Ralph Cox has one of the widest and deepest knowledge bases for patent law amongst UK solicitors.‘
The Doctors Laboratory Ltd / TDL Genetics Ltd
- Representing The Doctors Laboratory and TDL Genetics in a long-running series of patent infringement and validity proceedings relating to prenatal genetic testing (in particular for Down’s Syndrome).
D Young & Co LLP provides patent litigation representation alongside its top-tier drafting and prosecution services. The firm handles routine opposition defence before the EPO, such as co-head Anthony Albutt’s long-running defence of Nestlé’s liquid coffee pods. Co-head Kirk Gallagher provides opposition defence in the life sciences sector. Antony Craggs and Garreth Duncan recently initiated revocation proceedings in the English Patent Court concerning pesticides and other crop protection products.
‘Great attention to detail and absolutely focused on achieving the client’s objectives.’
‘Antony Craggs is very single-minded, with an in depth knowledge of the law.’
‘I have worked with D Young & Co for over 15 years. Prior to this I worked with other firms in three different continents, and none of them came close to the professionalism and dedication of D Young & Co.’
‘Even during the COVID-19 lockdown, D Young & Co carried on providing their top rate service with great success.’
‘The team is very responsive and easy to work with. They also grant us access to collaborative tools to share documents which are highly effective in huge litigations.’
‘Anthony Craggs is a great professional, he is very responsive and understands the needs of the clients. He is also very easy to work with.’
‘Anthony Albutt is really good to work with – he is friendly, super smart, grasps inventions really quickly and has a good way of asking the right questions to inventors to develop the invention.’
Apitope International NV
Asahi Kasei Corporation
Cancer Research Technology
Cell and Gene Therapy Catapult
Cyclacel Pharmaceuticals Inc.
Jo Loves Limited
King’s College London
Korean Institute of Science and Technology
Novo Nordisk A/S
Oxford University Innovation Limited
Plant Bioscience Ltd
Sony Interactive Entertainment
Sony Mobile Communications
Takeda Pharmaceutical Company Ltd
The Francis Crick Institute
The Lubrizol Corporation
The Pirbright Institute
Toyota Motor Corporation
University College London
University of Southampton
- Defended one of Teva’s main dosing regimen patents before the Opposition Division of the European Patent Office.
- Finchimica instructed the firm to advise on its claim to revoke two of Bayer AG’s patents directed to the use of N-alkyl carboxylic acid amides as penetration promoters. Proceedings were commenced before the English Patents Court in September 2019, with the action successfully settled in January 2020.
- Representing Nestlé at the EPO in the “coffee capsules wars”, protecting the client’s European patent rights concerning its well-known “Nescafé Dolce Gusto” capsules. These include appeals against rival Dutch company Douwe Egberts.
HGF Limited’s patent litigators have strength in the life sciences sector, as evidenced by Rachel Fetches’ representation of multinational generic pharmaceuticals companies in patent infringement defence and oppositions. Recent litigation highlights have involved the coordination of pan-European proceedings. Martyn Fish is currently involved in patent infringement litigation in the engineering sector, and also provides strategic advisory support regarding FRAND licensing to electronics and telecoms clients.
Good technical knowledge and common sense advice
IHC IQIP Limited
Glenmark Pharmaceuticals Europe Ltd
- Acting for IHC IQIP in a patent infringement action concerning the technology used to drive piles into the seabed as part of the construction process for wind farms.
Rebecca Halford–Harrison is a key name at Keystone Law for patent litigation services. Halford-Harrison is currently involved in patent infringement and licensing disputes across a diverse range of sectors including pharmaceuticals, manufacturing, energy and consumer products. Additionally, the team is advising on IP strategy and in the highly complex field of AI-driven competitive gaming technology. Corporate partners including Jeremy Schrire take on commercialisation, R&D and licensing matters.
‘Keystone are unique – as are their billing structures’
‘Rebecca Halford-Harrison is a very good and able IP lawyer and very personable’
Erda Energy Ltd
GRID eSports GmbH
McDonald’s Restaurants Limited
HP1 Technologies Limited
- Advising Erda in relation to licensing out its technology to Black Mountain Technologies.
Womble Bond Dickinson (UK) LLP’s acquisition of IP boutique James Love Legal has increased the firm’s contentious and non-contentious patent capabilities. Practice head James Love and senior counsel Patrick Cantrill (both based in Leeds) handle patent invalidation and infringement proceedings, oppositions, exploitation, commercialisation and other transactional matters, particularly for clients in the FMCG, retail, manufacturing and technology industries.
Other key lawyers:
‘Strong technical skills combined with commercial approach and a can-do attitude makes this my go-to team for contentious and non-contentious matters. Advice is always practical and solutions to problems meet our business needs.’
‘They get things done while avoiding the overly aggressive approach without purpose encountered at some of their competitors.’
‘James Love is highly responsive, offering technically adroit and clear commercial advice. He delegates well to his team and gives excellent value for money.’
Drax Group Plc
- Providing Geofabrics Limited – a UK manufacturer specialising in geotextiles and geocomposites for rail, structural drainage, landfill engineering, coastal and river defence – with contentious IP advice.
- Drax’s adviser for IP matters, including the IP aspects of a proposed investment, as well as drafting, negotiating and advising on the licensing of patents and knowhow.
- Instructed to act for Aydya in proceedings in the Patents Court involving taking action to invalidate two European patents owned by two overseas entities (one based in Hong Kong, the other in China) and to seek declarations of non-infringement of those patents.
Baker Botts (UK) LLP
Baker Botts (UK) LLP’s IP team enjoys a healthy stream of multijurisdictional patent litigation and commercial instructions from global energy and natural resources companies, leveraged by the firm’s top-tier US presence in those sectors. Practice head Neil Coulson is also retained by a number of life sciences clients. Recent instructions have involved freedom-to-operate and parallel import matters, joint ventures, passing-off and infringement disputes, licensing negotiations and other corporate pursuits.
The team is not the biggest in the City, but it is composed of extremely knowledgeable and highly efficient practitioners who get to the heart of the matter very quickly and always keep the client’s interests as their focus point.
Baker Botts has consistently continued to provide absolutely brilliant, insightful, excellent legal advice, primarily in relation to intellectual property but also general commercial issues. They are a listening and wise ear and we would be lost without them.
Neil Coulson is like a guardian legal angel providing swift , accurate, brilliant legal advice on intellectual property issues and also general commercial problems. He has the unusual mix of excellent commercial acumen, a brilliant legal mind and a wonderful sense of humour.
Neil Coulson is extremely knowledgeable and experienced but is very modest and approachable with it. He is a delight to work with.
Liberty Media Corporation
Royal National Institute for Blind People
Zix Corp Systems Inc
Clifford Chance’s IP partners regularly advise on large-scale, global transactions with significant patent assets at stake. Practice co-head Vanessa Marsland regularly assists with corporate acquisitions and disposals, patent licensing transactions and investments in the healthcare, life sciences, financial services and TMT sectors. Co-head Stephen Reese takes on patent licensing litigation, notably for big-ticket pharmaceutical companies.
Extensive knowledge of complex cross border situations
Took time to understand what we were trying to achieve and then provided options for moving forward.
Clear explanations meant we were not bogged down in the legal documentation necessary to achieve our goals.
FujiFilm Kyowa Kirin Biologics
Mastercard UK Limited
Melrose plc (GKN Limited)
Moorfields Eye Hospital NHS Trust
Philip Morris International
PIF (Saudi Arabia’s Public Investment Fund)
Receivers of British Steel Limited
Syncona & Quell Therapeutics
- Advised Saudi Arabia’s Public Investment Fund on its $2bn investment in Babylon.
- Advised Mastercard UK on its acquisition of Mets’ account-to-account services platform for €2.8bn.
- Advised FujiFilm Kyowa Kirin Biologics on its global patent settlement arrangements and its global patent license for the commercialisation of its monoclonal antibody Adalimumab.
Norton Rose Fulbright provides commercial IP advice, including in respect of patents, to a client portfolio of multinationals in the pharmaceutical, telecoms, FMCG and manufacturing sectors. Practice head Michael (Mike) Knapper recently assisted with licensing, R&D and rights acquisitions.
A good quality team
Seiko Hidaka is one of the nicest, most inquisitive solicitors working in IP in the UK. She has a sharp mind and a candid openness that is refreshing. Nothing is too hard, too obscure or too odd for her to research or investigate.
Lots of drive and energy: they are friendly, enthusiastic, professional and knowledgeable about the subject matter. Have the ability to put themselves in the client’s shoes.
Schweppes International Limited
- Advising a global manufacturer on dealing with SEP licence demands concerning multiple standards from one of the largest and most aggressive patent trolls in the market.
- Acting for a multinational pharmaceutical company in relation to its planned product launch which may interfere with existing licensing terms.
- Ongoing retainer for advice in relation to patents and trade secrets across the Suntory Food and Beverage Europe business unit.
Guildford-based Stevens & Bolton LLP provides SMEs and start-ups with scalable legal advice and fees for their patent licensing and commercialisation needs. The team, which is led by Tom Lingard, also advises larger global names in technology, life sciences, manufacturing and consumer electronics . Other lawyers to note in the practice, which also advises on licensing, patent protection strategy and entitlement disputes, include Charlotte Tillett .
Other key lawyers:
‘Stevens & Bolton has built an excellent team with Tom Lingard and Charlotte Tillet.‘
‘Whilst many firms say they can handle IP litigation, in particular patent litigation, Stevens & Bolton are one of the few regional firms who really can.‘
‘Tom Lingard and Charlotte Tillett are not only highly knowledgeable when it comes to IP, but they are also approachable and highly impressive in the company of clients.‘
Lonza Biologics plc
Samsung Electronics (UK) Limited
Brighton & Hove Albion Football Club
T.M. Lewin & Sons Ltd
McLaren Automotive Limited
PA Media Group Limited
FGX Europe Limited
Kia Motors (UK) Limited
Papa John’s (GB) Limited
Pret A Manger (Europe) Limited
- Advising Acro Aircraft Seating, which designs and manufactures seats for airline passengers, on a range of IP issues relating to the protection and exploitation of the intellectual property rights in its range of passenger aircraft seating, as well as providing clearance and infringement advice.
- Supporting Lonza Biologics in relation to its patent and knowhow licensing. This has involved working with the global licensing team to advise on, prepare and negotiate licenses relating to gene expression technology patents and knowhow.
- Advising a global semiconductor company on a patent entitlement dispute with a former employee.